C142H124F18N28O15 — CID 157205967
6-(azepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(1,3-dihydroisoindol-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methyl-1,4-diazepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methylpiperazin-1-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(9-oxo-2-azaspiro[4.4]nonan-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;4-(2-oxo-1,3-oxazolidin-3-yl)-3-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]benzamide (PubChem CID 157205967) has the molecular formula C142H124F18N28O15 and a molecular weight of 2804.70 g/mol. Its IUPAC name is 6-(azepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(1,3-dihydroisoindol-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methyl-1,4-diazepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methylpiperazin-1-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(9-oxo-2-azaspiro[4.4]nonan-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;4-(2-oxo-1,3-oxazolidin-3-yl)-3-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]benzamide.
| Compound Name | 6-(azepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(1,3-dihydroisoindol-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methyl-1,4-diazepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methylpiperazin-1-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(9-oxo-2-azaspiro[4.4]nonan-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;4-(2-oxo-1,3-oxazolidin-3-yl)-3-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]benzamide |
|---|---|
| PubChem CID | 157205967 |
| Molecular Formula | C142H124F18N28O15 |
| Molecular Weight | 2804.70 g/mol |
| Exact Mass | 2802.95 |
| IUPAC Name | 6-(azepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(1,3-dihydroisoindol-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methyl-1,4-diazepan-1-yl)-5-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(4-methylpiperazin-1-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-(9-oxo-2-azaspiro[4.4]nonan-2-yl)-5-pyrimidin-5-yl-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;4-(2-oxo-1,3-oxazolidin-3-yl)-3-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]benzamide |
| SMILES | CN1CCCN(c2ncc(C(=O)Nc3ccc(OC(F)(F)F)cc3)cc2-c2cccnc2)CC1.CN1CCN(c2ncc(C(=O)Nc3ccc(OC(F)(F)F)cc3)cc2-c2cncnc2)CC1.O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccc(N2CCOC2=O)c(-c2cccnc2)c1.O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CCC3(CCCC3=O)C2)c(-c2cncnc2)c1.O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CCCCCC2)c(-c2cccnc2)c1.O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2Cc3ccccc3C2)c(-c2cncnc2)c1 |
| InChI | InChI=1S/C25H22F3N5O3.C25H18F3N5O2.C24H24F3N5O2.C24H23F3N4O2.C22H21F3N6O2.C22H16F3N3O4/c26-25(27,28)36-19-5-3-18(4-6-19)32-23(35)16-10-20(17-11-29-15-30-12-17)22(31-13-16)33-9-8-24(14-33)7-1-2-21(24)34;26-25(27,28)35-21-7-5-20(6-8-21)32-24(34)18-9-22(19-10-29-15-30-11-19)23(31-12-18)33-13-16-3-1-2-4-17(16)14-33;1-31-10-3-11-32(13-12-31)22-21(17-4-2-9-28-15-17)14-18(16-29-22)23(33)30-19-5-7-20(8-6-19)34-24(25,26)27;25-24(26,27)33-20-9-7-19(8-10-20)30-23(32)18-14-21(17-6-5-11-28-15-17)22(29-16-18)31-12-3-1-2-4-13-31;1-30-6-8-31(9-7-30)20-19(16-11-26-14-27-12-16)10-15(13-28-20)21(32)29-17-2-4-18(5-3-17)33-22(23,24)25;23-22(24,25)32-17-6-4-16(5-7-17)27-20(29)14-3-8-19(28-10-11-31-21(28)30)18(12-14)15-2-1-9-26-13-15/h3-6,10-13,15H,1-2,7-9,14H2,(H,32,35);1-12,15H,13-14H2,(H,32,34);2,4-9,14-16H,3,10-13H2,1H3,(H,30,33);5-11,14-16H,1-4,12-13H2,(H,30,32);2-5,10-14H,6-9H2,1H3,(H,29,32);1-9,12-13H,10-11H2,(H,27,29) |
| InChIKey | ARJACQJPYYINOC-UHFFFAOYSA-N |
| XLogP | 28.26 |
| TPSA | 479.73 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 203 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2804.70 |
| LogP ≤ 5 | 28.26 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 36 |